CVS Health cuts prior authorizations, speeding approvals and expanding biosimilar use to reduce costs and improve patient access.

The huge pharmacy retail chain makes a puzzling store closure decision.

CVS Health (CVS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

In the first quarter of 2025, CVS Health’s CVS Health Care Benefits segment grew 8% year over year, mainly due to strength in Medicare. Elevated utilization trends in inpatient, outpatient and medical ...

CVS Health Corp. is shaking up its management ranks as newly installed Chief Executive Officer David Joyner tries to put his stamp on the health-care conglomerate. Thomas Cowhey, the current CFO, will ...

CVS Health experienced a significant share price decline in 2024, driven by earnings misses, CEO departure, and regulatory pressures on its PBM and Medicare Advantage businesses. Q4 2024 earnings ...

With 83 percent of Americans worrying about the rising price of prescriptions, CVS Health will roll out a comprehensive tool that alerts pharmacists to cheaper drug options when they fill patients’ ...